Abstract
INTRODUCTION
Gout is a common inflammatory arthritis with an increase in prevalence over the last 20 years. It currently affects over 8 million Americans. The clinical presentation of gout depends on the site of monosodium urate (MSU) crystals precipitation and the subsequent inflammatory response that ensues in the synovial joints and soft tissues. Gout usually manifests as a monoarticular arthritis in the lower extremities. If untreated, nodular masses of MSU crystals called tophi may eventually deposit in extraarticular locations, such as, the axial skeleton. Although tradi tionally thought of as a rare complication, recent study suggests that axial gout may be more prevalent than suspected [1] . Gout affecting the spinal column will typically present with neurological compromise, localized pain, and lytic vertebral lesions [2, 3] . Spinal gout can affect the facet joint, laminae, ligamentum flavum, as well as the epidural space [4] . From 2000 to 2014, approximately 68 case reports have been published on spinal gout. The current manu script summarizes the most common presenting features, imaging findings, and treatment choices based on the 68 published cases. A case is also presented to provide illustration on the topic.
MATERIALS AND METHODS

Literature review
A PubMed literature search using the key words spinal gout, from January 2000 to December 2014, limited to human studies and restricted to English language literature resulted in 221 publications. Abstracts and articles were then reviewed for content. Articles kept for review included patients who underwent treatment for spinal gout. Furthermore, data required for inclusion in the study included: Patient demographics, clinical presentation, laboratory findings, imaging studies, and treatment methods were collected (Table 1) . Articles excluded from the study were those that did not have patients diagnosed with spinal gout and those that did not include patient demographics, clinical presentation, laboratory findings, imaging studies, and treatment methods. After review, a total of 54 peer reviewed articles met the above criteria and were included for data collection.
RESULTS
The 54 articles accounted for 68 cases of spinal gout with 51 (75%) males and 17 (25%) females and an average age of 59.2 years, 41(60.3%) had prior history of peripheral gout (Table 1) .
Clinical presentations
Of the 68 spinal gout patients reviewed, 47 (69.1%) presented with localized back/neck pain, 38 (55.9%) with some form of spinal cord compression, defined as weakness, numbness, loss of bladder or bowel control, and decreased sensation below the compression level, 17 (25%) with spinal nerve root compression or radiculo pathy, defined as motor dysfunction or dysesthesia along the course of a specific nerve caused by compression of its root, 13 (19.1%) with fever, 1 (1.5%) with cranial nerve palsy, and 2 (3.0%) with atlantoaxial subluxation (Table 2) . Furthermore, among the sites of involvement in the 68 spinal gout patients, 38 (55.9%) were located in the lumbar region, 15 (22.1%) in the thoracic region, 15 (22.1%) in the cervical region, and 1 (1.4%) in an unspecified region (Table 3) . One patient demonstrated soft tissue nodularity consistent with gouty tophi on biopsy in both the thoracic and lumbar spinal segments.
Laboratory studies
Laboratory studies of the 68 recorded cases showed 45 (66.2%) with elevated uric acid level at the time of diagnoses, 17 (25%) had elevated erythrocyte sedi mentation rates (ESR), 19 (27.9%) had increased Creactive proteins (CRP) level, 11 (16.2%) had renal insufficiency, 9 (13.2%) had leukocytosis, and 5 (7.4%) had anemia (Table 4) .
Imaging studies
On the T1weighted magnetic resonance imaging (MRI) images, 28 (41.2%) did not report findings, 31 (45.5%) were hypointense, 8 (11.8%) were isointense, and 1 (1.5%) was heterointense. On T2weighted images, 24 (35.3%) did not report findings, 18 (26.5%) were hypointense, 12 (17.6%) were heterointense, 11 (16.2%) were hyperintense, and 4 (5.9%) were isointense. A gadolinium (Gd)enhanced MRI scan was obtained from 32 (47.1%) patients. These findings are referenced in (Table 5) .
Thirtyseven cases (54.4%) did not report Xray findings, 12 (17.6%) showed spondylosis or spondyl isthesis, 8 (11.8%) showed bony erosion, 6 (8.8%) were unremarkable, and 5 (7.4%) showed degenerative changes. In addition, 35 (51.5%) did not report computed tomography (CT) findings, 13 (19.1%) showed bony erosion and high density attenuation, 13 (19.1%) [9] 70 M L5-S1 [12] 72 M L4-S1 [12] 83 M T9-T11 LE weakness 1 mo Y NA NA N Hypo Hypo Y Lamina 11 2002 Hsu et al [12] 27 M L2-S1
Back [25] 65 F L5-S1 Back pain, LE weakness 10 mo N NA NA NA Iso Hetero Y L5-S1 lamina 30 2006 Dharmadhikari et al [26] 66 F C3-C7 Cord compression, quadriparesis, falls 2006 Hou et al [27] 37 M L5-S1
Back pain, fever 2006 Oaks et al [28] 32 M T5-T8 [31] 77 M L5-S1 [32] 65 [32] 63 M L4-S1 Chronic LE pain and paresthesia, claudication [33] 55 [38] 62 F C6-C7
Neck pain NA N Y NA Y NA NA NA NA 44 2010 Ko et al [39] 63 M L5-S1
Low [48] 29 M L4-S1
Severe [53] 25 M T9-T10, L3-S1 
Treatments
Fortyfive (66.2%) patients had surgical treatment. Thirty five (51.5%) patients had laminectomies, 8 (11.8%) of whom also had fusions with laminectomies, 7 (10.3%) had surgeries not otherwise specified, 1 (1.5%) had a vertebrectomy, 2 (2.9%) had discectomies with partial corpectomies. Twenty (29.4%) received medical treatment alone and 3 (4.4%) did not report any treatment (Table 6 ).
Case illustration
A 58yearold female presented with a chief complaint of low back and radicular pain over left L4, 5 dermatomes that had been progressively worsening over a four month duration to the point where she was unable to walk. The patient denied any saddle paresthesia or change in bowel and bladder function. She has a history of cardiovascular disease, chronic kidney disease (stage Ⅰ), type Ⅱ diabetes mellitus, hypertension, obesity, and obstructive sleep apnea. The patient also described an acute gouty arthropathy that was diagnosed in her right hand about 4 mo prior for which she was taking colchicine. An inflammatory workup was ordered which showed CRP of 3.58 (n < 1.0), ESR 25 (020), WBC 6.2 (4.010.0), uric acid 11.4 (2.56.8); HLAB27, antiDNA, Rheumatoid factor, and complement labs were negative. Plain radiograph of the lumbar spine was unremark 66 2013 Yoon et al [54] 64 able. Plain radiograph of the right hand showed osseous erosive changes at the 4 th finger distal interphalangeal (DIP) joint (Figure 1 ). MRI showed intraspinal extradural lesion causing spinal canal stenosis at L4S1 ( Figure  2) . A CT showed that the lesion was calcified with erosive changes noted at the left L45 facet joint and L 4 lamina (Figure 3) . The patient was treated with L4S1 decompression, instrumentation and fusion. The surgical microscope was used during excision of the intraspinal lesion, which appeared chalky white, nonadherent and easily pealed off the thecal sac without sustaining dural tear (Figure 4 ). Postoperatively the patient noted significant improvement in both low back and radicular pain. The patient received allopurinol treatment for gout and remained asymptomatic at the last follow up two years after the index procedure.
DISCUSSION
Gout is a common form of inflammatory arthritis caused by the deposition of MSU crystals in synovial joints that result into erosion and joint damage. Soft tissue masses of MSU crystals known as tophi are usually found in the hand and extensor surface of the forearm [4, 32, 57] . Tophi are seen in patients with longstanding gout, but can also be one of the first symptoms amongst a cluster of metabolic disorders leading to hyperuricemia, especially 
A B
Elgafy H et al . Spinal gout: A review with case illustration among those with longstanding renal impairment [2, 33] . Tophi are a common manifestation of gout, but spinal manifestations are considered rare. Recent research by de Mello et al [1] , however, suggests that tophi in the axial skeleton may be more prevalent than first suspected.
Although no studies have been able to conclude the exact mechanism for axial involvement in gout, the likely theory is, as gout usually involves joint spaces, facet joint may be the initial deposition location for MSU crystals. Another theory is based on the fact that high uric acid and other inflammatory markers are often elevated in gout. This increase in uric acid in the blood could signal a corresponding increase in cerebrospinal fluid (CSF) leading to the obstruction of the canal or foramen.
Literature review showed that the lumbar spine was the most commonly involved region followed by thoracic and cervical regions. The most common clinical presentation was back pain associated with lumbar radiculopathy, or neurogenic claudication. The most frequent laboratory finding was hyperuricemia defined as uric acid above 7 mg/dL. Renal insufficiency was also found in many patients. Plain radiograph findings are usually nonspecific. The most consistent image findings of the intraspinal extradural tophi were hypointense signal on the T1weighted MRI and heterointense signals on the T2weighted MRI. Spinal gout is usually diagnosed with cytological or histopathological studies. However, for patients treated with surgery, a pasty chalkwhite mass are usually present. Clinical presentations and radiological findings of spinal gout are often nonspecific and one has to consider the differential diagnoses of intraspinal extradural mass. The most frequent etiology with similar clinical presentations and imaging findings is herniated disc. Other causes include synovial cyst, tumor, epidural abscess, arteriovenous malformation. Pharmacotherapy for spinal gout is the same as those used for gout involving typical joints. Acute gouty attack is most often treated with nonsteroidal anti inflammatory drugs (NSAIDs), such as, naproxen or indomethacin. In patients with chronic kidney disease, duodenal or gastric ulcer, heart disease or hypertension, NSAID allergy, or anticoagulant treatment, colchicine is an alternative treatment. While NSAIDs and colchicine are effective in symptomatic reduction during an acute attack, they do not prevent the development of bony erosions or tophi deposits in tissues. To prevent further gouty attack, maintenance medications are often prescribed with the goal of keeping uric acid level less than 6 mg/dL. Xanthine oxidase inhibitors, such as allopurinol, febuxostat, and oxypurinol, are the first line choices for reduced production of uric acid. Allopurinol can precipitate gouty attack or worsen current attack, thus, it is used for maintenance after acute attack has resolved. Uricosuric agents, such as, probenecid and sulfinpyrazone, are second line prophylactics aimed to increase uric acid excretion since decreased uric acid excretion is responsible for 85% to 90% of primary or secondary hyperuricemia [58] . Surgical interventions may be needed if patient has symptoms of spinal cord or nerve root compression. The mainstay of surgical treatment is decompression and excision of the tophi. The role of fusion at the time of the decompression remains controversial. The need for fusion is influenced by symptomatic preoperative instability as evidenced by dynamic radiographs, erosion of the facet joint seen on CT scan, or intraoperative instability that may be created by iatrogenic resection of spinal structures such as the pars interarticularis or the facet joints.
Although this article provides a broad overview of cases involving spinal gout since January 2000, there are some limitations. The absence of certain information, such as the posttreatment outcomes, limited the depth of our analysis in certain cases. Furthermore, the literature review could not always account for indi vidual variation among the 68 cases reviewed including the particular method of diagnosis, which was not standardized across all patients included in the study. In addition, the individual articles did not provide information regarding prior uric acid lowering treatments, which could possibly inflate the number of spinal gout cases with normal uric acid levels.
The majority of clinical features for spinal gout such as back pain and neurological symptoms are nonspecific. Thus, one must rule out other common diagnoses, such as disc herniation, tumor, infection prior to diagnosing a patient with spinal gout. Laboratory study indicative of gout is elevated uric acid levels. In this literature review, the majority of the cases utilized MRI as the radiological study of choice in detecting spinal gout. While MRI was the major noninvasive diagnostic method, all suspicious findings on imaging required surgical sampling for pathological confirmation of negatively birefringent MSU crystals presence.
COMMENTS
Background
Gout is a common inflammatory arthritis with an increase in prevalence over the last 20 years. It currently affects over 8 million Americans. The primary aim of this review is to summarize the most common presenting features, imaging findings, and treatment choices based on the 68 published cases.
Research frontiers
Literature review showed that the lumbar spine was the most commonly involved region followed by thoracic and cervical regions. The most common clinical presentation was back pain associated with lumbar radiculopathy, or neurogenic claudication. The most frequent laboratory finding was hyperuricemia defined as uric acid above 7 mg/dL.
Innovations and breakthroughs
Traditionally gout thought of as a rare problem characterized by a sudden, severe attacks of pain, redness and tenderness in joints, often the joint at the base of the big toe. Recent studies suggest that axial gout may be more prevalent than suspected. Spinal gout can affect the facet joint, laminae, ligamentum flavum, as well as the epidural spaces.
Applications
The majority of clinical features for spinal gout such as back pain and neurological symptoms are nonspecific. Suspicious findings on MRI imaging required surgical sampling for pathological confirmation of negatively birefringent monosodium urate crystals presence.
Peer-review
It is a good review concerning the spinal gout consisting of the symptom and signs, treatment option and lab data analysis.
